De Monitor - Pharming Professor schreef op 23 maart 2021 21:36:
[...]
Q1? Q3
Sijmen de Vries - CEO Pharming Group.
Q: Wen can we expect the first results in de Covid-19 trials you are running?
I would say that this is
purely speculative here, that in the third quarter, there
could be
some reporting from these -- from
either one of these trials. And
I'm not sure at this point in time which trial will actually be able to report first. Because our U.S. trials also -- our own trial is also very active and has a different longer -- lower dose per day, but a longer duration of treatment. And we're -- but yes, so the third quarter is
probably a reasonable
expectation that there
could be
some news from that.
Maar dat zal zoals gewoonlijk wel weer uitlopen. De einddatum voor het Bazel onderzoekje staat ook al voor 2022.